Produkty 2479914-04-8

CAS 2479914-04-8 występuje w naszej ofercie pod nazwami: 4-Pregnen-11beta,17alpha-diol-3,20-dione-2,2,4,6,6,21,21,21-d8, 96 atom % D, min 98% Chemical Purity, 21–Deoxycortisol–d8, 21-Deoxycortisol-d8, 98.79%. Oferty producentów: CDN, GLPBio, MedChemExpress. Dostępne opakowania: 0,01g, 0,005g, 1mg, 1 mg.

4-Pregnen-11beta,17alpha-diol-3,20-dione-2,2,4,6,6,21,21,21-d8, 96 atom % D, min 98% Chemical Purity
CDN
  • opakowanie: 0,01g, 0,005g
  • Warianty: 2
Zobacz produkt
21–Deoxycortisol–d8
GLPBio
  • opakowanie: 1mg
  • Warianty: 1
od 1860,77
Zobacz produkt
21-Deoxycortisol-d8, 98.79%
MedChemExpress
  • opakowanie: 1 mg
  • Warianty: 1
od 1294,93
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8S,9S,10R,11S,13S,14S,17R)-2,2,4,6,6-pentadeuterio-11,17-dihydroxy-10,13-dimethyl-17-(2,2,2-trideuterioacetyl)-7,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one (CAS 2479914-04-8) to związek chemiczny o wzorze sumarycznym C21H30O4 i masie molowej 354.5 g/mol. Nazwa systematyczna IUPAC: (8S,9S,10R,11S,13S,14S,17R)-2,2,4,6,6-pentadeuterio-11,17-dihydroxy-10,13-dimethyl-17-(2,2,2-trideuterioacetyl)-7,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one. InChIKey: LCZBQMKVFQNSJR-ZERYXUNYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H30O4
Masa molowa354.5 g/mol
Nazwa IUPAC(8S,9S,10R,11S,13S,14S,17R)-2,2,4,6,6-pentadeuterio-11,17-dihydroxy-10,13-dimethyl-17-(2,2,2-trideuterioacetyl)-7,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one
InChIKeyLCZBQMKVFQNSJR-ZERYXUNYSA-N
SMILES[2H]C1=C2[C@](CC(C1=O)([2H])[2H])([C@H]3[C@H](C[C@]4([C@H]([C@@H]3CC2([2H])[2H])CC[C@@]4(C(=O)C([2H])([2H])[2H])O)C)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 21-Deoxycortisol-d8, 4-Pregnen-11beta,17alpha-diol-3,20-dione-2,2,4,6,6,21,21,21-d8, 21-Dehydrohydrocortisone-d8, orb2300192, 21-Deoxycortisol-d8 Solution in Acetonitrile, 100ug/mL, 4-Pregnen-11?,17?-diol-3,20-dione-2,2,4,6,6,21,21,21-d8
Powiązane formy tego związku
(8S,9S,10R,11S,13S,14S,17R)-17-acetyl-11,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O4
(8S,9S,10R,11R,13S,14S,17R)-17-acetyl-11,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O4
Izomery (ten sam wzór sumaryczny)
(9S,10S)-6,6,9-trimethyl-3-pentyl-8,10-dihydro-7H-benzo[c]chromene-1,9,10-triol C21H30O4
[(1S,2S,4R,6S,8S,11R,12S,14R,16R,17S)-2,17-dimethyl-5,15-dioxahexacyclo[9.8.0.02,8.04,6.012,17.014,16]nonadecan-16-yl] acetate C21H30O4
(8R,9S,10R,13S,14S,16R,17S)-17-acetyl-16,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O4
(8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O4
(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O4
(8S,9S,10R,11R,13S,14S,17S)-11,17-dihydroxy-2-(hydroxymethyl)-10,13,17-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H30O4
(6R,8R,9S,10R,13S,14S,17R)-17-acetyl-6,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O4
(5R,8S,9S,10S,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,11-dione C21H30O4
3-methyl-1-[2,4,6-trihydroxy-3,5-bis(3-methylbut-2-enyl)phenyl]butan-1-one C21H30O4
[(3S,7R,8R,9S,10R,13S,14S)-7-hydroxy-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate C21H30O4